The Man Who Saw Things on Carvedilol.

Author: AikoyeSalisu A, JafferanyMohammad, OsuagwuVanessa, PlathDianne L

Paper Details 
Original Abstract of the Article :
The newer generation non selective vasodilating beta adrenergic blocking agent Carvedilol, also has an alpha 1 adrenoceptor antagonistic effect and is widely used in treating various cardiovascular diseases. It is a selective alpha and non-selective beta blocker. It's side effects are vast and not l...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/31250422

データ提供:米国国立医学図書館(NLM)

Carvedilol: A Double-Edged Sword in the Treatment of Cardiovascular Diseases

Carvedilol, a widely used non-selective beta-blocker, plays a crucial role in treating various cardiovascular conditions. However, this study explores the neuropsychiatric side effects of this medication, focusing on the rare yet concerning occurrence of hallucinations. The authors present a case report, highlighting the potential for Carvedilol to induce hallucinations, a phenomenon rarely reported with other beta-blockers.

Carvedilol: A Potential for Unforeseen Side Effects

This case report reminds us that even seemingly safe and effective medications like Carvedilol can have unexpected side effects. Think of it as discovering a hidden desert mirage, seemingly alluring but potentially deceptive. While hallucinations are rare, this study emphasizes the importance of vigilance and careful monitoring for any unexpected neurological or psychiatric changes in patients taking Carvedilol.

Navigating the Risks and Benefits of Carvedilol

This study serves as a valuable reminder that all medications have potential risks and benefits. It highlights the need for a thorough assessment of a patient's individual needs and potential risk factors before prescribing Carvedilol. It also emphasizes the importance of open communication between patients and healthcare providers, ensuring that any concerns or changes in mental status are addressed promptly.

Dr.Camel's Conclusion

Carvedilol is a valuable tool in managing cardiovascular diseases, but this study reminds us that even the most trusted medications can have hidden complexities. Just as a traveler must be aware of the dangers lurking in a desert, we must approach the use of Carvedilol with vigilance and caution, monitoring for potential side effects and ensuring patient safety. By understanding the intricacies of medication use, we can navigate the desert of medical treatment with greater knowledge and awareness.

Date :
  1. Date Completed 2019-08-19
  2. Date Revised 2019-08-19
Further Info :

Pubmed ID

31250422

DOI: Digital Object Identifier

31250422

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.